International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Perphenazine 0.5 mg/mL Oral Liquid

Author(s): Allen Loyd V Jr

Issue: Mar/Apr 2019 - Volume 23, Number 2
View All Articles in Issue

Page(s): 151

Perphenazine 0.5 mg/mL Oral Liquid Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Perphenazine 0.5 mg/mL Oral Liquid. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: Loyd V. Allen Jr., PhD, RPh, perphenazine, formulation, piperazine phenothiazine derivative, antipsychotic agents, psychosis, psychotic disorders, psychiatric disorders

Related Categories: FORMULATIONS, MENTAL HEALTH, NEUROLOGY

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Perphenazine 0.5 mg/mL Oral Liquid Allen Loyd V Jr	Mar/Apr 2019 Pg. 151
Rapid-Dissolve Technology: An Interview With Loyd V. Allen, Jr., PhD, RPh Allen Loyd V Jr	Nov/Dec 2003 Pg. 449-450
Basics of Compounding for Disorders of the External Ear Allen Loyd V Jr	Jan/Feb 2004 Pg. 46-48
Basics of Compounding for Cough Allen Loyd V Jr	Nov/Dec 2004 Pg. 462-465
Compounding in the Pharmacy Curriculum: Beyond the Basics Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 181-185
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Chemical Stability of Perphenazine in Two Commercially Available Vehicles for Oral Liquid Dosage Forms Gupta Vishnu D	Jul/Aug 2008 Pg. 372-374
Haloperidol 0.5-mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Sep/Oct 2021 Pg. 417
Chemical Stability of Perphenazine in Oral Liquid Dosage Forms Gupta Vishnu D	Nov/Dec 2005 Pg. 484-486
Prednisolone 1 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	May/Jun 2020 Pg. 229
Aripiprazole 1 mg/mL in Oral-Plus:Ora-Sweet (1:1) Oral Suspension Allen Loyd V Jr	Jul/Aug 2019 Pg. 314
Prednisolone Sodium Phosphate 1.4 mg/mL in SyrSpend SR pH4, Cherry Flavored Allen Loyd V Jr	Nov/Dec 2019 Pg. 487
Perphenazine 5-mg/mL Injection Allen Loyd V Jr	Sep/Oct 2003 Pg. 378
Perphenazine 4-mg and Amitriptyline HCl 10-mg capsules Allen Loyd V Jr	Jul/Aug 2003 Pg. 303
Methylprednisolone 4-mg/mL Oral Suspension Allen Loyd V Jr	Jul/Aug 2011 Pg. 340
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Williams LaVonn A, Fokken Dawn	Sep/Oct 2009 Pg. 386-389
Perphenazine 2.5-mg/5-mL Syrup Allen Loyd V Jr	Nov/Dec 2003 Pg. 473
Quetiapine Fumarate 40-mg/mL Nonaqueous Oral Suspension Allen Loyd V Jr	Jul/Aug 2011 Pg. 342
Compounded Analgesic Therapy for Disorders of Movement: Arthritis, Neuropathic Pain, and Postpolio Syndrome Brown Scott, Erickson Brian, Muller George, Bryant-Snure Susan J, Mestayer Richard F III	May/Jun 2010 Pg. 182-192
Penfluridol, a Unique Psychiatric Medicine for the Treatment of Chronic Schizophrenia Zur Eyal	Mar/Apr 2019 Pg. 113-119
Return to Top